The role of HER2 in human carcinogenesis was first established when it was discovered that ~15–20% of breast cancers show HER2 amplification and overexpression, a genetic feature associated with aggressive biologic behavior and worse prognosis [13]. This evidence concerns the gene ERBB2 and breast cancer.